Skip to main content
TipRanks
Go Ultimate75% OFF

Sun Pharmaceutical Industries Limited (SUNPHARMA) Stock Statistics & Valuation Metrics

24 Followers

Total Valuation

Sun Pharmaceutical Industries Limited has a market cap or net worth of INR 4.49T. The enterprise value is INR 4.07T.

Market Cap
INR 4.49T
Enterprise Value
INR 4.07T

Share Statistics

Sun Pharmaceutical Industries Limited has 2,399,278,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
2,399,278,300
Owned by Insiders
―
Owned by Institutions
7.04%

Financial Efficiency

Sun Pharmaceutical Industries Limited’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 11.46%.

Return on Equity (ROE)
0.14
Return on Assets (ROA)
0.11
Return on Invested Capital (ROIC)
11.46%
Return on Capital Employed (ROCE)
0.16
Revenue Per Employee
12.44M
Profits Per Employee
2.44M
Employee Count
47,000
Asset Turnover
0.54
Inventory Turnover
2.25

Valuation Ratios

The current PE Ratio of Sun Pharmaceutical Industries Limited is 40.95. Sun Pharmaceutical Industries Limited’s PEG ratio is 8.50.

PE Ratio
40.95
PS Ratio
7.29
PB Ratio
5.03
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
8.50

Income Statement

In the last 12 months, Sun Pharmaceutical Industries Limited had revenue of 584.62B and earned 114.79B in profits. Earnings per share was 47.80.

Revenue
584.62B
Gross Profit
325.62B
Operating Income
135.53B
Pretax Income
150.63B
Net Income
114.79B
EBITDA
183.40B
Earnings Per Share (EPS)
47.80

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

Sun Pharmaceutical Industries Limited pays an annual dividend of INR 5.00, resulting in a dividend yield of 0.85%

Dividend Per Share
INR 5.00
Dividend Yield
0.85%
Payout Ratio
31.37%
Free Cash Flow Yield
0.00%
Earnings Yield
2.44%

Stock Price Statistics

Beta
0.49
52-Week Price Change
6.40%
50-Day Moving Average
1813.21
200-Day Moving Average
1821.81
Relative Strength Index (RSI)
62.40
Average Volume (3m)
106.08K

Important Dates

Sun Pharmaceutical Industries Limited upcoming earnings date is Feb 04, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 30, 2026
Next Earnings Date
Feb 04, 2027
Ex-Dividend Date
Jul 07, 2026

Financial Position

Sun Pharmaceutical Industries Limited as a current ratio of 2.82, with Debt / Equity ratio of 5.54%

Current Ratio
2.82
Quick Ratio
2.31
Debt to Market Cap
0.01
Net Debt to EBITDA
-0.38
Interest Coverage Ratio
39.99

Taxes

In the past 12 months, Sun Pharmaceutical Industries Limited has paid 35.54B in taxes.

Income Tax
35.54B
Effective Tax Rate
0.24

Enterprise Valuation

Sun Pharmaceutical Industries Limited EV to EBITDA ratio is 23.50, with an EV/FCF ratio of 0.00.

EV to Sales
7.01
EV to EBITDA
23.50
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

Sun Pharmaceutical Industries Limited has INR 335.70B in cash and marketable securities with INR 32.41B in debt, giving a net cash position of INR 303.29B billion.

Cash & Marketable Securities
INR 335.70B
Total Debt
INR 32.41B
Net Cash
INR 303.29B
Net Cash Per Share
INR 126.41
Tangible Book Value Per Share
INR 273.39

Margins

Gross margin is 55.92%, with operating margin of 23.17%, and net profit margin of 17.79%.

Gross Margin
55.92%
Operating Margin
23.17%
Pretax Margin
24.32%
Net Profit Margin
17.79%
EBITDA Margin
29.82%
EBIT Margin
24.94%

Analyst Forecast

The average price target for Sun Pharmaceutical Industries Limited is INR 2,025.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
INR 2,025.00
Price Target Upside
8.16% Upside
Analyst Consensus
Moderate Buy
Analyst Count
2
Revenue Growth Forecast
12.13%
EPS Growth Forecast
4.94%

Scores

Smart Score
―
AI Score
69